Skip to main content

Clinical Drug Investigation

Ausgabe 12/2019

Inhalt (12 Artikel)

Acknowledgement

Acknowledgement to Referees

Open Access Original Research Article

Evaluation of the Feasibility of a Web-Based Survey to Assess Patient-Reported Symptom Improvement and Treatment Satisfaction Among Patients with Psoriatic Arthritis Receiving Secukinumab

Marina Magrey, Michael Bozyczko, Daniel Wolin, Margaret Mordin, Lori McLeod, Eric Davenport, Costel Chirila, Peter Hur

Open Access Original Research Article

Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy

Hisamitsu Ishihara, Susumu Yamaguchi, Toshifumi Sugitani, Yoshinori Kosakai

Open Access Original Research Article

Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects

Dénes Csonka, Shirin Bruderer, Armin Schultz, Marianne Soergel, Radka Stepanova, Giancarlo Sabattini, Juan Jose Perez-Ruixo

Open Access Short Communication

Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study

Esther Merlini, Federico A. Cazzaniga, Anna Casabianca, Chiara Orlandi, Mauro Magnani, Giuseppe Ancona, Camilla Tincati, Antonella d’Arminio Monforte, Giulia Marchetti

Research Letter

Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient with Metastatic Gastric Adenocarcinoma

Masataka Nishikawa, Atsushi Goshima, Hajime Owaki, Takeshi Fuji

Research Letter

Non-Vitamin K Antagonist Oral Anticoagulant Treatment in Centenarians: A Series of Four Cases

Yuval Kuntzman, Eyal Zimlichman, Howard Amital, Shmuel Tiosano